• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Differential Regulation of Progesterone Receptor-Mediated Transcription by CDK2 and DNA-PK.细胞周期蛋白依赖性激酶2(CDK2)和DNA依赖性蛋白激酶(DNA-PK)对孕激素受体介导转录的差异调节
Mol Endocrinol. 2016 Feb;30(2):158-72. doi: 10.1210/me.2015-1144. Epub 2015 Dec 11.
2
Cyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A/Cdk2 as a progesterone receptor coactivator.细胞周期蛋白依赖性激酶活性是孕激素受体功能所必需的:细胞周期蛋白A/细胞周期蛋白依赖性激酶2作为孕激素受体共激活因子的新作用。
Mol Cell Biol. 2005 Jan;25(1):264-77. doi: 10.1128/MCB.25.1.264-277.2005.
3
Partial agonist activity of the progesterone receptor antagonist RU486 mediated by an amino-terminal domain coactivator and phosphorylation of serine400.由氨基末端结构域共激活因子和丝氨酸400磷酸化介导的孕酮受体拮抗剂RU486的部分激动剂活性。
Mol Endocrinol. 2010 Feb;24(2):335-45. doi: 10.1210/me.2008-0081. Epub 2009 Dec 11.
4
Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.钙/钙调蛋白激酶抑制剂以及免疫抑制剂大环内酯类药物雷帕霉素和FK506可抑制人乳腺癌T47D细胞中孕激素和糖皮质激素受体介导的转录。
Mol Endocrinol. 1998 Jul;12(7):986-1001. doi: 10.1210/mend.12.7.0128.
5
An amino-terminal truncated progesterone receptor isoform, PRc, enhances progestin-induced transcriptional activity.一种氨基末端截短的孕激素受体亚型PRc可增强孕激素诱导的转录活性。
Mol Endocrinol. 1996 Nov;10(11):1379-87. doi: 10.1210/mend.10.11.8923464.
6
Effects of hormone and cellular modulators of protein phosphorylation on transcriptional activity, DNA binding, and phosphorylation of human progesterone receptors.激素和蛋白质磷酸化细胞调节剂对人孕激素受体转录活性、DNA结合及磷酸化的影响
Mol Endocrinol. 1992 Apr;6(4):607-20. doi: 10.1210/mend.6.4.1316549.
7
Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1).孕酮对乳腺癌细胞生长的双相调节:细胞周期蛋白依赖性激酶抑制剂p21和p27(Kip1)的作用
Mol Endocrinol. 1997 Oct;11(11):1593-607. doi: 10.1210/mend.11.11.0006.
8
The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation.拮抗剂RU486和ZK98299在体外和体内均能刺激孕酮受体与脱氧核糖核酸结合,但对受体构象有不同影响。
Endocrinology. 1998 Apr;139(4):1905-19. doi: 10.1210/endo.139.4.5944.
9
R5020 and RU486 act as progesterone receptor agonists to enhance Sp1/Sp4-dependent gene transcription by an indirect mechanism.R5020和米非司酮作为孕激素受体激动剂,通过间接机制增强Sp1/Sp4依赖的基因转录。
Mol Endocrinol. 2007 Mar;21(3):635-50. doi: 10.1210/me.2006-0274. Epub 2006 Dec 27.
10
Regulation of progesterone receptor activity by cyclin dependent kinases 1 and 2 occurs in part by phosphorylation of the SRC-1 carboxyl-terminus.细胞周期蛋白依赖性激酶 1 和 2 通过 SRC-1 羧基末端的磷酸化部分调节孕激素受体的活性。
Int J Biochem Cell Biol. 2011 Aug;43(8):1157-67. doi: 10.1016/j.biocel.2011.04.009. Epub 2011 Apr 21.

引用本文的文献

1
DNA-PKcs, a player winding and dancing with RNA metabolism and diseases.DNA依赖蛋白激酶催化亚基(DNA-PKcs),一个与RNA代谢及疾病共舞的参与者。
Cell Mol Biol Lett. 2025 Mar 4;30(1):25. doi: 10.1186/s11658-025-00703-z.
2
Characterization of flavonoids with potent and subtype-selective actions on estrogen receptors alpha and beta.对雌激素受体α和β具有强效和亚型选择性作用的黄酮类化合物的特性研究。
iScience. 2024 Feb 20;27(3):109275. doi: 10.1016/j.isci.2024.109275. eCollection 2024 Mar 15.
3
A novel ERβ high throughput microscopy platform for testing endocrine disrupting chemicals.一种用于测试内分泌干扰化学物质的新型雌激素受体β高通量显微镜平台。
Heliyon. 2023 Dec 8;10(1):e23119. doi: 10.1016/j.heliyon.2023.e23119. eCollection 2024 Jan 15.
4
A molecular toolbox to study progesterone receptor signaling.研究孕激素受体信号转导的分子工具包。
J Mammary Gland Biol Neoplasia. 2023 Nov 29;28(1):24. doi: 10.1007/s10911-023-09550-0.
5
Global signalling network analysis of luminal T47D breast cancer cells in response to progesterone.腔面型T47D乳腺癌细胞对孕酮反应的全局信号网络分析
Front Endocrinol (Lausanne). 2022 Aug 11;13:888802. doi: 10.3389/fendo.2022.888802. eCollection 2022.
6
DNA-PKcs: A Targetable Protumorigenic Protein Kinase.DNA-PKcs:一种可靶向的促肿瘤发生蛋白激酶。
Cancer Res. 2022 Feb 15;82(4):523-533. doi: 10.1158/0008-5472.CAN-21-1756.
7
Targeted and systemic insights into the crosstalk between DNA-dependent protein kinase catalytic subunit and receptors of estrogen, progesterone and epidermal growth factor in the context of cancer.靶向和系统地洞察 DNA 依赖性蛋白激酶催化亚基与癌症环境中雌激素、孕激素和表皮生长因子受体之间的串扰。
Mol Biol Rep. 2022 Jan;49(1):587-594. doi: 10.1007/s11033-021-06797-w. Epub 2021 Nov 3.
8
A Mechanistic High-Content Analysis Assay Using a Chimeric Androgen Receptor That Rapidly Characterizes Androgenic Chemicals.一种使用嵌合雄激素受体的机制高通量分析测定法,可快速表征雄激素类化学物质。
SLAS Discov. 2020 Aug;25(7):695-708. doi: 10.1177/2472555220922917. Epub 2020 May 11.
9
Pleiotropic Impact of DNA-PK in Cancer and Implications for Therapeutic Strategies.DNA-PK 在癌症中的多效性影响及其治疗策略的意义。
Clin Cancer Res. 2019 Sep 15;25(18):5623-5637. doi: 10.1158/1078-0432.CCR-18-2207. Epub 2019 Jul 2.
10
Leveraging Image-Derived Phenotypic Measurements for Drug-Target Interaction Predictions.利用图像衍生的表型测量进行药物-靶点相互作用预测。
Cancer Inform. 2019 Jun 12;18:1176935119856595. doi: 10.1177/1176935119856595. eCollection 2019.

本文引用的文献

1
Cyclin A2 and its associated kinase activity are required for optimal induction of progesterone receptor target genes in breast cancer cells.细胞周期蛋白A2及其相关激酶活性是乳腺癌细胞中孕酮受体靶基因最佳诱导所必需的。
J Steroid Biochem Mol Biol. 2014 Oct;144 Pt B(0 0):471-82. doi: 10.1016/j.jsbmb.2014.09.009. Epub 2014 Sep 16.
2
Defining estrogenic mechanisms of bisphenol A analogs through high throughput microscopy-based contextual assays.通过基于高通量显微镜的情境分析确定双酚A类似物的雌激素机制。
Chem Biol. 2014 Jun 19;21(6):743-53. doi: 10.1016/j.chembiol.2014.03.013. Epub 2014 May 22.
3
Systems level-based RNAi screening by high content analysis identifies UBR5 as a regulator of estrogen receptor-α protein levels and activity.基于系统水平的RNA干扰筛选通过高内涵分析鉴定出UBR5作为雌激素受体α蛋白水平和活性的调节因子。
Oncogene. 2015 Jan 8;34(2):154-64. doi: 10.1038/onc.2013.550. Epub 2014 Jan 20.
4
Adaptive reprogramming of the breast cancer kinome.乳腺癌激酶组的适应性重编程。
Clin Pharmacol Ther. 2014 Apr;95(4):413-5. doi: 10.1038/clpt.2014.8. Epub 2014 Jan 10.
5
Progesterone stimulates progenitor cells in normal human breast and breast cancer cells.孕激素刺激正常人类乳腺和乳腺癌细胞中的祖细胞。
Breast Cancer Res Treat. 2014 Feb;143(3):423-33. doi: 10.1007/s10549-013-2817-2. Epub 2014 Jan 7.
6
DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin.NU7441 抑制 DNA-PK 可增强乳腺癌细胞对电离辐射和阿霉素的敏感性。
Breast Cancer Res Treat. 2014 Jan;143(1):47-55. doi: 10.1007/s10549-013-2785-6. Epub 2013 Nov 29.
7
Targeted therapy for breast cancer.乳腺癌的靶向治疗。
Am J Pathol. 2013 Oct;183(4):1096-1112. doi: 10.1016/j.ajpath.2013.07.005. Epub 2013 Aug 27.
8
Proteomic analysis of coregulators bound to ERα on DNA and nucleosomes reveals coregulator dynamics.蛋白质组学分析结合 ERα 的核心调节子在 DNA 和核小体上揭示了核心调节子的动态变化。
Mol Cell. 2013 Jul 25;51(2):185-99. doi: 10.1016/j.molcel.2013.06.007. Epub 2013 Jul 11.
9
Phosphorylation: a fundamental regulator of steroid receptor action.磷酸化:甾体激素受体作用的基础调节因子。
Trends Endocrinol Metab. 2013 Oct;24(10):515-24. doi: 10.1016/j.tem.2013.05.008. Epub 2013 Jul 6.
10
Coactivators enable glucocorticoid receptor recruitment to fine-tune estrogen receptor transcriptional responses.共激活因子使糖皮质激素受体能够招募到精细调节雌激素受体转录反应。
Nucleic Acids Res. 2013 Apr;41(7):4036-48. doi: 10.1093/nar/gkt100. Epub 2013 Feb 26.

细胞周期蛋白依赖性激酶2(CDK2)和DNA依赖性蛋白激酶(DNA-PK)对孕激素受体介导转录的差异调节

Differential Regulation of Progesterone Receptor-Mediated Transcription by CDK2 and DNA-PK.

作者信息

Treviño Lindsey S, Bolt Michael J, Grimm Sandra L, Edwards Dean P, Mancini Michael A, Weigel Nancy L

机构信息

Departments of Molecular and Cellular Biology (L.S.T., M.J.B., S.L.G., D.P.E., M.A.M., N.L.W.) and Pathology and Immunology (S.L.G., D.P.E.), Baylor College of Medicine, Houston, Texas 77030.

出版信息

Mol Endocrinol. 2016 Feb;30(2):158-72. doi: 10.1210/me.2015-1144. Epub 2015 Dec 11.

DOI:10.1210/me.2015-1144
PMID:26652902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4792227/
Abstract

Progesterone receptor (PR) function is altered by cell signaling, but the mechanisms of kinase-specific regulation are not well defined. To examine the role of cell signaling in the regulation of PR transcriptional activity, we have utilized a previously developed mammalian-based estrogen-response element promoter array cell model and automated cell imaging and analysis platform to visualize and quantify effects of specific kinases on different mechanistic steps of PR-mediated target gene activation. For these studies, we generated stable estrogen-response element array cell lines expressing inducible chimeric PR that contains a swap of the estrogen receptor-α DNA-binding domain for the DNA-binding domain of PR. We have focused on 2 kinases important for steroid receptor activity: cyclin-dependent kinase 2 and DNA-dependent protein kinase. Treatment with either a Cdk1/2 inhibitor (NU6102) or a DNA-dependent protein kinase inhibitor (NU7441) decreased hormone-mediated chromatin decondensation and transcriptional activity. Further, we observed a quantitative reduction in the hormone-mediated recruitment of select coregulator proteins with NU6102 that is not observed with NU7441. In parallel, we determined the effect of kinase inhibition on hormone-mediated induction of primary and mature transcripts of endogenous genes in T47D breast cancer cells. Treatment with NU6102 was much more effective than NU7441, in inhibiting induction of PR target genes that exhibit a rapid increase in primary transcript expression in response to hormone. Taken together, these results indicate that the 2 kinases regulate PR transcriptional activity by distinct mechanisms.

摘要

孕激素受体(PR)的功能会因细胞信号传导而改变,但激酶特异性调节的机制尚未明确。为了研究细胞信号传导在PR转录活性调节中的作用,我们利用了先前开发的基于哺乳动物的雌激素反应元件启动子阵列细胞模型以及自动化细胞成像和分析平台,以可视化和量化特定激酶对PR介导的靶基因激活不同机制步骤的影响。在这些研究中,我们构建了稳定的雌激素反应元件阵列细胞系,其表达可诱导的嵌合PR,该嵌合PR包含将雌激素受体α的DNA结合结构域替换为PR的DNA结合结构域。我们重点研究了对类固醇受体活性重要的两种激酶:细胞周期蛋白依赖性激酶2和DNA依赖性蛋白激酶。用Cdk1/2抑制剂(NU6102)或DNA依赖性蛋白激酶抑制剂(NU7441)处理可降低激素介导的染色质解聚和转录活性。此外,我们观察到用NU6102处理后,激素介导的某些共调节蛋白募集出现定量减少,而用NU7441处理则未观察到这种情况。同时,我们确定了激酶抑制对内源性基因在T47D乳腺癌细胞中激素介导的初级转录本和成熟转录本诱导的影响。在抑制PR靶基因的诱导方面,用NU6102处理比用NU7441处理有效得多,这些靶基因在激素刺激下初级转录本表达迅速增加。综上所述,这些结果表明这两种激酶通过不同机制调节PR转录活性。